Correlation Between Cue Biopharma and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Terns Pharmaceuticals, you can compare the effects of market volatilities on Cue Biopharma and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Terns Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and Terns Pharmaceuticals
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cue and Terns is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and Terns Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Terns Pharmaceuticals. In addition to that, Cue Biopharma is 1.33 times more volatile than Terns Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 1,315 in Terns Pharmaceuticals on August 29, 2024 and sell it today you would lose (727.00) from holding Terns Pharmaceuticals or give up 55.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Cue Biopharma |
| Terns Pharmaceuticals |
Cue Biopharma and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Terns Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |